![conference banner](/images/conference-banner.jpeg)
Abstract
The term dietary fibre describes a wide range of highly divergent (mainly polysaccharide) compounds that escape digestion before the colon. Fibre is often regarded as a neutral dietary compound, not interacting with the gut and only offering dietary benefit by the consequent absence of calorific macronutrients, or by bulking out luminal content. Although the above benefits are apparent, a number of other physiological effects of dietary fibres in the colon have previously been described. This review outlines these previous observations in terms of the effect of various fibre types on (i) colonic luminal contents (including the resident microflora (ii) the first line of colonic protection, the mucus barrier (iii) the underlying colonic mucosa (iv) the colonic musculature and (v) colonic neurohumoural release, and the subsequent effect on control of gut motility and satiety. This review will further highlight the divergent physiological effects of various fibre types, and their potential health benefits.
Keywords: Dietary fibre, colon, mucus, satiety, PYY, morphology
Current Nutrition & Food Science
Title: The Interaction of Dietary Fibres with the Colon
Volume: 2 Issue: 3
Author(s): Iain A. Brownlee, Peter W. Dettmar, Vicki Strugala and Jeff P. Pearson
Affiliation:
Keywords: Dietary fibre, colon, mucus, satiety, PYY, morphology
Abstract: The term dietary fibre describes a wide range of highly divergent (mainly polysaccharide) compounds that escape digestion before the colon. Fibre is often regarded as a neutral dietary compound, not interacting with the gut and only offering dietary benefit by the consequent absence of calorific macronutrients, or by bulking out luminal content. Although the above benefits are apparent, a number of other physiological effects of dietary fibres in the colon have previously been described. This review outlines these previous observations in terms of the effect of various fibre types on (i) colonic luminal contents (including the resident microflora (ii) the first line of colonic protection, the mucus barrier (iii) the underlying colonic mucosa (iv) the colonic musculature and (v) colonic neurohumoural release, and the subsequent effect on control of gut motility and satiety. This review will further highlight the divergent physiological effects of various fibre types, and their potential health benefits.
Export Options
About this article
Cite this article as:
Brownlee A. Iain, Dettmar W. Peter, Strugala Vicki and Pearson P. Jeff, The Interaction of Dietary Fibres with the Colon, Current Nutrition & Food Science 2006; 2 (3) . https://dx.doi.org/10.2174/157340106778017896
DOI https://dx.doi.org/10.2174/157340106778017896 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |
Call for Papers in Thematic Issues
Bioactive compounds, functional foods, metabolism, and health
Nutrition, metabolism, and their intervention strategies have become focal points of interest in the study of metabolic syndrome and health. Bioactive compounds, phytochemicals, and functional foods play crucial roles in modulating metabolic processes and improving human health. Moreover, the composition of the gut microbiome is also believed to be closely ...read more
Harnessing Bioactive Compounds from Food Waste: Sustainable Extraction Strategies and Health Applications
Food waste presents a significant challenge across the postharvest cycle, from agricultural production to distribution. However, within this waste lies a treasure trove of bioactive chemicals that hold immense potential for nutraceuticals, functional foods, and postharvest additives, including antimicrobials. Various extraction methods, such as solvent extraction (SE), supercritical fluid extraction ...read more
Related Journals
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chronic Inflammatory Diseases and the Acute Respiratory Distress Syndrome (ARDS)
Current Pharmaceutical Design The Risk of Progressive Multifocal Leukoencephalopathy Under Biological Agents Used in the Treatment of Chronic Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) The Protective Effects of Extra Virgin Olive Oil on Immune-mediated Inflammatory Responses
Endocrine, Metabolic & Immune Disorders - Drug Targets Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
Current Protein & Peptide Science Recent Developments in Therapeutic Approaches for Lysosomal Storage Diseases
Recent Patents on CNS Drug Discovery (Discontinued) The Role of Adenosine in Rheumatoid Arthritis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons
Current Cardiology Reviews Impact of Ultrasound Contrast Agents in Echocardiographic Assessment of Ischemic Heart Disease
Recent Patents on Cardiovascular Drug Discovery Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications
Current Medicinal Chemistry Abnormal Clock Gene Expression and Locomotor Activity Rhythms in Two Month-Old Female APPSwe/PS1dE9 Mice
Current Alzheimer Research Aldosterone Receptor Antagonists and Cardiovascular Disease: Do We Need a Change of the Guard?
Cardiovascular & Hematological Agents in Medicinal Chemistry Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease
Current Alzheimer Research Interindividual Variability in the Efficacy of Oral Antiplatelet Drugs: Definitions, Mechanisms and Clinical Importance
Current Pharmaceutical Design It’s Time to Talk: Challenges in Providing Integrated Palliative Care in Advanced Congestive Heart Failure. A Narrative Review
Current Cardiology Reviews The Effect of Levosimendan on Two Distinct Rodent Models of Parkinson’s Disease
Current Alzheimer Research CA125: An Increasingly Promising Biomarker of Heart Failure
Current Pharmaceutical Design Efficacy of the Newest COX-2 Selective Inhibitors in Rheumatic Disease
Current Pharmaceutical Design Therapeutic Agents Against COVID-19 with Clinical Evidence
Current Pharmaceutical Design Recent Patents on Oral Combination Drug Delivery and Formulations
Recent Patents on Drug Delivery & Formulation The Use of Ghrelin and Ghrelin Receptor Agonists as a Treatment for Animal Models of Disease: Efficacy and Mechanism
Current Pharmaceutical Design